138 results
Page 5 of 7
8-K
EX-99.1
wmpxln0o5a78fg 8t5
26 Aug 19
Departure of Directors or Certain Officers
9:04am
8-K
EX-99.1
q9vr f4q1hwylzc7m4w
21 Aug 19
Roxadustat Approved In China for Treatment of Anemia In Chronic Kidney Disease Patients Not Receiving Dialysis
4:39pm
8-K
EX-99.1
yzfmu 46bp
8 Aug 19
Fibrogen Reports Second Quarter 2019 Financial Results
4:15pm
8-K
EX-99.1
fbpi p1mhig53vxrnzj
24 Jul 19
Other Events
9:46pm
8-K
EX-99.2
td7ek56keplsmenrn
24 Jul 19
Other Events
9:46pm
8-K
EX-99.1
u7pvyk79x
22 Jul 19
Other Events
8:00am
8-K
EX-99.1
lhqywb okn
5 Jun 19
Fibrogen Appoints Suzanne Blaug to Board of Directors
5:15pm
8-K
EX-99.1
kseum49avs8
9 May 19
Fibrogen Reports First Quarter 2019 Financial Results
4:15pm
8-K
EX-99.1
hic 24lypinh
15 Apr 19
Other Events
9:00am
8-K
EX-99.1
bu1usz1s6ol7jk1s2
27 Feb 19
Fibrogen Reports Fourth Quarter and Full Year 2018 Financial Results
12:00am
8-K
EX-99.1
ba5npoie 2u0p0c
7 Jan 19
Regulation FD Disclosure
8:52am
8-K
EX-99.1
aehyyb7z 9rr6gegja0
20 Dec 18
FibroGen Announces Positive Topline Results from Three Global Phase 3
8:30am
8-K
EX-99.1
s3fvwlpfa
18 Dec 18
FibroGen Announces Approval of Roxadustat in China for the Treatment of
12:00am
8-K
EX-99.1
1dvxram7ps0buj1wt7
6 Dec 18
Fibrogen Appoints Maykin Ho, PH.D., to Board of Directors
6:09am
8-K
EX-99.1
j30x oo9lm7qklpxy7o2
8 Nov 18
FIBROGEN REPORTS third QUARTER 2018 FINANCIAL RESULTS
4:05pm